Table 2.
Characteristics of the subjects included in the study.
| Not infected (protected) | Infected (unprotected) | ||
|---|---|---|---|
| Total (51) | (n = 27) | (n = 24) | |
| Sex (N°) | |||
| M | 20 | 11 | 9 |
| F | 32 | 16 | 16 |
| Age (years) | |||
| Mean ± SD | 37.6 ± 10.6 | 36.5 ± 10.1 | 38.9 ± 10.9 |
| Range | 26–63 | 26–63 | 26–62 |
| Time from serum collection to diagnosis of infection (days) | |||
| Mean ± SD | 13.3 ± 5.1 | ||
| Range | 6–21 | ||
| Smoking | 5 | 3 | 2 |
| BMI | 23.4 ± 2.5 | 23.4 ± 2.4 | 23.3 ± 1.7 |
| Symptoms (N° of patients) | |||
| Fever | 14 | ||
| Cough | 10 | ||
| Rhinorrhea | 5 | ||
| Headache | 11 | ||
| Anosmia | 12 | ||
| Ageusia | 11 | ||
| Asthenia | 10 | ||
| Myalgia/Arthralgia | 6 | ||
| Other symptoms | 13 | ||
| Asymptomatic | 4 | ||
| Symptomatic | 20 | ||